DarioHealth Reports Third Quarter 2026 Financial Results: Year-over-Year Revenue Growth and Operating Expense Reduction

Third quarter 2026 revenue increased 6% year-over-year and 3% sequentially to $5.3 million GAAP gross margin was 59%, compared to 60% in the third quarter of 2025; non-GAAP business-to-business-to-consumer ("B2B2C") gross margin remained at approximately 80% for the 11th consecutive...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.